Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 4: Summary of Regulatory Updates from NMPA/CDE and Other Agencies
Release time：2026-07-06
share:
Previous article：Issue 5: Focusing on the revised GCP and other new pharmaceutical regulations
next article：Issue 3: Innovative Drugs and AI Empowerment: A Quick Look at New Pharma Regulations
Back to list
You may also want to read
Issue 13: Monthly Report on Core Policies of Pharmaceutical Regulations for June-July 2026
2026.07.24
Warm congratulations to Nanjing Mingjie Biopharmaceutical Awarded as the Best Service Provider of Leecan Pharmaceutical in 2024!
2025.04.03
Lead product R & D and manufacturing upgrading with technological innovation, and provide the market with more competitive high-quality products with advanced technology and stringent standards
2026.04.22
